Analyst Consensus ?
ConsensusBuy16 ratings
Bullish1487.5%
Neutral212.5%
Bearish00.0%
FN2 Earnings Intelligence
Roivant Sciences Ltd. analyst ratings
Roivant Sciences Ltd. (ROIV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$41.96Current
$10Low
$32.09Average
$55High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | Maintain | Nov 10, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 28, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Oct 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | Sep 9, 2026 |
| Guggenheim | Buy | Buy | Maintain | Sep 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 16, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Dec 15, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 15, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 18, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 18, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 3, 2024 |
| Truist Securities | Buy | Buy | Maintain | Mar 25, 2024 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Sep 18, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Dec 19, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Oct 26, 2021 |
Named analyst price targets
Upside is calculated against the persisted current price $41.96. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $51 | $39.57 | +21.5% | Sep 16, 2026 |
| Guggenheim | Yastin Suneja | $46 | $41.48 | +9.6% | Sep 9, 2026 |
| UBS | Analyst unavailable | $55 | $41.48 | +31.1% | Sep 9, 2026 |
| H.C. Wainwright | Analyst unavailable | $47 | $42.03 | +12.0% | Sep 8, 2026 |
| Jefferies | Analyst unavailable | $52 | $41.7 | +23.9% | Sep 8, 2026 |
| H.C. Wainwright | Douglas Tsao | $41 | $35.12 | -2.3% | Aug 7, 2026 |
| Guggenheim | Yastin Suneja | $36 | $29.96 | -14.2% | May 26, 2026 |
| Cowen & Co. | Analyst unavailable | $41 | $32.18 | -2.3% | May 21, 2026 |
| Leerink Partners | David Risinger | $42 | $32.41 | +0.1% | May 21, 2026 |
| Piper Sandler | Analyst unavailable | $40 | $29.26 | -4.7% | Apr 16, 2026 |
| H.C. Wainwright | Douglas Tsao | $34 | $28.81 | -19.0% | Mar 4, 2026 |
| H.C. Wainwright | Analyst unavailable | $33 | $27.67 | -21.4% | Feb 10, 2026 |
| Jefferies | Analyst unavailable | $30 | $26.44 | -28.5% | Feb 9, 2026 |
| Guggenheim | Analyst unavailable | $30 | $25.82 | -28.5% | Feb 9, 2026 |
| Guggenheim | Analyst unavailable | $28 | $22.3 | -33.3% | Dec 18, 2025 |
| Leerink Partners | David Risinger | $32 | $22.1 | -23.7% | Dec 15, 2025 |
| H.C. Wainwright | Analyst unavailable | $26 | $21.46 | -38.0% | Dec 12, 2025 |
| Guggenheim | Yastin Suneja | $25 | $20.56 | -40.4% | Nov 14, 2025 |
| Leerink Partners | David Risinger | $29 | $21.17 | -30.9% | Nov 11, 2025 |
| Jefferies | Analyst unavailable | $20 | $15.47 | -52.3% | Sep 18, 2025 |
| Guggenheim | Analyst unavailable | $21 | $15.24 | -50.0% | Sep 18, 2025 |
| H.C. Wainwright | Analyst unavailable | $20 | $15.24 | -52.3% | Sep 18, 2025 |
| Leerink Partners | David Risinger | $17 | $11.92 | -59.5% | Oct 21, 2024 |
| Goldman Sachs | Corinne Jenkins | $17 | $12.06 | -59.5% | Sep 19, 2024 |
| Bank of America Securities | Chi Fong | $12.5 | $12.46 | -70.2% | Sep 11, 2024 |
| Piper Sandler | Allison Bratzel | $20 | $10.39 | -52.3% | May 31, 2024 |
| H.C. Wainwright | Douglas Tsao | $18 | $10.92 | -57.1% | Apr 3, 2024 |
| Deutsche Bank | Neena Bitritto-Garg | $15 | $10.92 | -64.3% | Apr 3, 2024 |
| Goldman Sachs | Corinne Jenkins | $18 | $10.92 | -57.1% | Apr 2, 2024 |
| Goldman Sachs | Corinne Jenkins | $16 | $10.62 | -61.9% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $14 | $7.56 | -66.6% | Jan 5, 2023 |
| Leerink Partners | Analyst unavailable | $10 | $7.32 | -76.2% | Dec 19, 2022 |
| Citigroup | Analyst unavailable | $10 | $4.04 | -76.2% | Aug 18, 2022 |
| Goldman Sachs | Analyst unavailable | $12 | $3.86 | -71.4% | May 24, 2022 |
Track every rating change on ROIV the moment it posts. Free to start.
Start freeGet the ROIV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.